Conduit Pharmaceuticals Inc.

#132 in public CDT public

CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets.

https://newhedge.io/api/v2/companies/conduit-pharmaceuticals-inc/bitcoin-acquisitions

API Documentation

API Access Required

API access is available with our Advanced plan.

Bitcoin Holdings

Total Bitcoin ₿ 17.909 BTC

% of 21M Supply 0.0%

Current Value $1,119,779

Cost Basis $2,002,506

ROI -44.08%

% of Company 44.0%

mNAV

2.27x

BTC/Share ₿ 0.00045454 BTC

Market Cap $2,545,775

Enterprise Value $2,545,775

Latest Purchase Oct 17, 2025

Avg. cost / BTC $111,816

Conduit Pharmaceuticals Inc. Stock Priced in BTC

0.000008 BTC

Conduit Pharmaceuticals Inc. Bitcoin Holdings Over Time

₿ 17.909 BTC

Bitcoin Acquisitions History

Type	BTC Change	Holdings	Transaction Value	Date
Buy	+0 BTC	0 BTC	$0	—
Buy	+0 BTC	0 BTC	$0	—
Buy	+0 BTC	0 BTC	$0	—
Buy	+0 BTC	0 BTC	$0	—
Buy	+0 BTC	0 BTC	$0	—
Get instant access to full data Register for free

Financial Highlights

Revenue (TTM) $0

Profit Margin 0%

Operating Margin 0%

ROE 0%

ROA -344.95%

EPS $-1177.89

Book Value $-77.816

Current Volume 624,707

Avg Volume (30d) 14,375,120

Volume vs Avg 0.04x

Conduit Pharmaceuticals Inc. Stock Price vs Bitcoin

$0.49 / $62,525

Company Overview

CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It also provides treatments for inflammatory disorders, oncology, dermatology, rare diseases and animal health. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.

Sector Healthcare

Industry Biotechnology

Sub-Industry Life Sciences Tools & Services

Employees 4

Exchange NASDAQ

Fiscal Year End December

IPO Date September 2023

Website Visit Website

Stock Returns

Share Price $0.49

1W Return -30.7%

1M Return -41.73%

3M Return -90.31%

1Y Return -99.91%

1Y vs BTC -56.2%

52W High $586.00

% Down from 52W High -99.9%

Key Executives

Dr. Andrew Regan Founder, CEO & Director

Age: 59

Dr. Joanne M. Holland Chief Scientific Officer

Age: 51

Company Details

Address 4581 Tamiami Trail North, Naples, FL, United States, 34103

Phone 646 491 9132

ISIN US20678X2053

CIK 0001896212

Currency USD

Most Recent Quarter 2026-03-31

Growth Metrics

Earnings Growth (YoY) 0%

Revenue Growth (YoY) 0%

Balance Sheet (Q1 2026)

Total Assets $3,459,424,000

Total Liabilities $2,176,423,000

Total Equity $1,283,001,000

Cash & Equivalents $0

Total Debt $0

Current Assets $1,279,887,000

Current Liabilities $613,634,000

Long-term Debt $0

Additional Financials

EBITDA -$24,738,000

Gross Profit $0

Revenue per Share $0

Diluted EPS (TTM) $-1177.89

Outstanding Shares 39,400

EPS Estimates

Current Quarter $0

Current Year $0

Next Quarter $0

Next Year $0

Recent Insider Activity

Name	Title	Type	Shares	Price	Value	Date
Ltd Nirland	INSIDER	Sell	3	$30000.00	$90,000	Oct 07, 2024
Ltd Nirland	INSIDER	Sell	4	$30000.00	$120,000	Oct 04, 2024
Ltd Nirland	INSIDER	Sell	1	$30000.00	$30,000	Oct 02, 2024
Ltd Nirland	INSIDER	Sell	3	$36000.00	$108,000	Sep 30, 2024
Andrew Regan	Founder, CEO & Director	Sell	5	$78000.00	$390,000	Jul 17, 2024
Andrew Regan	Founder, CEO & Director	Sell	3	$75000.00	$225,000	Jul 15, 2024
Andrew Regan	Founder, CEO & Director	Sell	4	$75000.00	$300,000	Jul 12, 2024
Andrew Regan	CONGRESSIONAL	Sell	—	$99000.00	—	Jul 10, 2024
Andrew Regan	CONGRESSIONAL	Sell	—	$153000.00	—	Jul 08, 2024
Andrew Regan	CONGRESSIONAL	Sell	—	$192000.00	—	Jul 03, 2024
Get instant access to full data Register for free

Major Holders

Major Institutional Holders

Tower Research Capital LLC

0.0023%

1 shares

Morgan Stanley - Brokerage Accounts

0 shares

Apollon Wealth Management, LLC

0 shares

BNP Paribas Arbitrage, SA

0 shares

SBI Securities Co Ltd

0 shares

Virtu Financial LLC

0 shares

Major Mutual Fund Holders

Fidelity Extended Market Index

0.0794%

31 shares

Fidelity Nasdaq Composite Index

0.0406%

16 shares

Fidelity Series Total Market Index

0.001%

0 shares

Spartan Total Market Index Pool G

0.0006%

0 shares

Frequently Asked Questions

Common questions about Conduit Pharmaceuticals Inc.'s Bitcoin holdings

How much Bitcoin does Conduit Pharmaceuticals Inc. hold?

Conduit Pharmaceuticals Inc. currently holds 17.909 BTC, which represents 0.0% of the total Bitcoin supply (21 million). This makes them the 132nd largest public Bitcoin holder.

What is the current value of Conduit Pharmaceuticals Inc.'s Bitcoin holdings?

As of today, Conduit Pharmaceuticals Inc.'s Bitcoin holdings are worth approximately $1,119,779. This represents 44.0% of the company's total market value.

What is Conduit Pharmaceuticals Inc.'s average cost basis for Bitcoin?

Conduit Pharmaceuticals Inc.'s average cost basis for their Bitcoin purchases is $2,002,506 per Bitcoin. Their current return on investment (ROI) is -44.08%.

When did Conduit Pharmaceuticals Inc. last buy Bitcoin?

Conduit Pharmaceuticals Inc.'s most recent Bitcoin purchase was Oct 17, 2025. View purchase details

What type of company is Conduit Pharmaceuticals Inc.?

Conduit Pharmaceuticals Inc. is a public company in the Healthcare sector and Biotechnology industry with approximately 4 employees .

What is Conduit Pharmaceuticals Inc.'s market capitalization?

Conduit Pharmaceuticals Inc. has a market capitalization of approximately $2,545,775 and annual revenue of $0 .

What is Conduit Pharmaceuticals Inc.'s mNAV?

Conduit Pharmaceuticals Inc.'s mNAV (Market-to-Net Asset Value) is 2.27x, comparing the company's market value to its Bitcoin holdings value. An mNAV of 1.0 means market value equals Bitcoin stash, while >1.0 indicates a premium for the company's Bitcoin strategy.

What is Conduit Pharmaceuticals Inc.'s market cap and enterprise value?

Conduit Pharmaceuticals Inc. has a market capitalization of $2,545,775 and an enterprise value of $2,545,775. Enterprise value represents the total company value including debt and cash, providing a more complete valuation picture than market cap alone.

Conduit Pharmaceuticals Inc.

Bitcoin Holdings

Conduit Pharmaceuticals Inc. Stock Priced in BTC

Conduit Pharmaceuticals Inc. Bitcoin Holdings Over Time

Bitcoin Acquisitions History

Financial Highlights

Conduit Pharmaceuticals Inc. Stock Price vs Bitcoin

Company Overview

Stock Returns

Key Executives

Company Details

Growth Metrics

Balance Sheet (Q1 2026)

Additional Financials

EPS Estimates

Recent Insider Activity

Major Holders

Frequently Asked Questions

How much Bitcoin does Conduit Pharmaceuticals Inc. hold?

What is the current value of Conduit Pharmaceuticals Inc.'s Bitcoin holdings?

What is Conduit Pharmaceuticals Inc.'s average cost basis for Bitcoin?

When did Conduit Pharmaceuticals Inc. last buy Bitcoin?

What type of company is Conduit Pharmaceuticals Inc.?

What is Conduit Pharmaceuticals Inc.'s market capitalization?

What is Conduit Pharmaceuticals Inc.'s mNAV?

What is Conduit Pharmaceuticals Inc.'s market cap and enterprise value?

Other public Companies

BTC-B.SE

Cango Inc

MAXST Co Ltd

Bitmine Immersion Technologies, Inc.

Mode Global Holdings